ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏

🔗 https://bit.ly/3G14rIW

#HemeSky #ASHAwards

Need further training in the care of VWD patients? Apply today to “Von Willebrand Disease – From Theory to Clinical Practice” Workshop in Malmö, Sweden April 1-3, 2025. Travel awards sponsored by Octapharma. Full details in the link below!

htrs.smapply.org/prog/von_wil...

I discuss the biological basis of new #hemophilia therapies.

ow.ly/azsR50V3XBP

🩸New Blood issue out now featuring:
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals

Among patients with IgA nephropathy, treatment with iptacopan, which inhibits the alternative complement pathway, resulted in a significant reduction in proteinuria as compared with placebo. Full APPLAUSE-IgAN trial results and Research Summary: nej.md/3UmrOkh

#MedSky #Nephrology

In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT

#MedSky #Oncology

New Pulse episode alert!🎙️

How do you go from mentee to mentor—and then collaborator? 🤝In today's episode, we chat w/@aswolberg.bsky.social & @kmachlus.bsky.social about the power of mentorship, building community, and finding your niche in science. @gbarnesmd.bsky.social

🎧Tune in: bit.ly/3Q3Q6wI

On the anniversary of Dr Erik Adolf von Willebrand's birth, we're marking European #VonWillebrandDisease Awareness Day. More than a century after he first recognised VWD, we still don't know enough about its daily impact. Can you help us change that?

#HemeSky #MedSky #beVWDaware #VWDunited

A new editorial describes the science behind a clinical trial reported by Ruff et al. in which a monoclonal antibody targeting factors XI and XIa was evaluated for its effects on bleeding events in patients with atrial fibrillation. Read the full editorial: nej.md/3Eg76gw

#MedSky #ScienceSky

We are hiring 😀

Postdoctoral position – Stem cells, Cancer, and Aging

We study cell fate decision and lineage specification in hematopoietic stem and multipotent progenitor populations to modulate lineage output for therapeutic purpose in diseases and aging contexts.